Path: /proteins/abcac4-protein
Title: ABCA4 Protein (ABCA4)
Tags: section:proteins, kind:protein
| ABCA4 Protein (ABCA4) |
|---|
| Gene | [ABCA4](/genes/abc4) |
| UniProt ID | O78379 |
| PDB Structures | None available |
| Molecular Weight | ~221 kDa |
| Subcellular Localization | Outer segment discs of photoreceptor cells, retinal pigment epithelium |
| Protein Family | ABC transporter A subfamily |
| Length | 2,273 amino acids |
| Associated Diseases | Stargardt disease, retinitis pigmentosa, age-related macular degeneration |
ABCA4 (ATP-binding cassette transporter A4) is a 2,273-amino acid protein belonging to the ABC transporter family, primarily expressed in photoreceptor cells and retinal pigment epithelium (RPE)[@allikmets1997]. It plays a critical role in visual cycle function and retinal homeostasis, with mutations causing inherited retinal dystrophies affecting millions of people worldwide.
ABCA4 is a member of the ATP-binding cassette (ABC) transporter family, specifically the A subfamily. Unlike many ABC transporters that are involved in drug efflux and multidrug resistance, ABCA4 has evolved a specialized function in the retina, where it transports retinoid compounds essential for the visual cycle[@weng1999]. The protein is expressed exclusively in photoreceptor outer segments, where it mediates the ATP-dependent transport of N-retinylidene-phosphatidylethanolamine (N-retinylidene-PE) across the disc membrane.
ABCA4 has the typical ABC transporter architecture, adapted for its specialized role in photoreceptor cells:
¶ Transmembrane Domains
- Two transmembrane domains (TMD): 12 transmembrane helices spanning the disc membrane
- Extracellular loops: Form the substrate entry site for retinoid compounds
- Intracellular loops: Connect TMDs and contain regulatory elements
¶ Nucleotide-Binding Domains
- Two nucleotide-binding domains (NBD): ATP-binding cassettes with Walker A/B motifs
- ABC signature (C-loop): Contains the conserved LSGGQ motif
- H-loop (switch region): Contains the catalytic histidine
- N-terminal extracellular domain: Unique to the ABCA subfamily
- Coupling helix: Connects TMD to NBD for conformational transmission
- Dimerization: The protein forms a functional homodimer in the membrane
ABCA4 shares structural features with other ABCA subfamily members:
- ABCA1: Cholesterol transporter, implicated in Alzheimer's disease
- ABCA2: Brain-expressed, associated with Alzheimer's disease risk
- ABCA3: Lung surfactant homeostasis
- ABCA4: Retinal-specific visual cycle function
ABCA4 performs essential functions in the visual cycle[@sun2019]:
ABCA4 flips N-retinylidene-phosphatidylethanolamine from outer to inner leaflet of disc membranes[@weng1999]. This function is critical because:
- All-trans-retinal released from rhodopsin during phototransduction binds to phosphatidylethanolamine (PE) to form N-retinylidene-PE
- ABCA4 transports this compound to the inner leaflet where it can be processed
- This prevents accumulation of toxic retinoid compounds in the outer segment
¶ Photoreceptor Outer Segment Maintenance
ABCA4 is essential for proper disc shedding and renewal:
- Supports daily renewal of ~10% of outer segment
- Maintains disc membrane lipid composition
- Enables proper rhodopsin localization
ABCA4 supports RPE function through:
- Visual cycle and rhodopsin regeneration
- Phagocytosis of photoreceptor outer segments
- Prevention of toxic lipofuscin accumulation
ABCA4 regulates phosphatidylethanolamine and phosphatidylglycerol distribution:
- Maintains membrane asymmetry
- Supports lipid rafts for signaling
- Prevents lipid peroxidation
ABCA4 facilitates the recycling of retinaldehyde for rhodopsin regeneration:
- All-trans-retinal → 11-cis-retinal conversion
- Supports dark adaptation
- Enables continuous phototransduction
ABCA4 mutations cause Stargardt disease, the most common inherited retinal dystrophy[@cremers2020]:
- Prevalence: 1 in 10,000 individuals
- Inheritance: Autosomal recessive
- Age of onset: Childhood to adolescence
- Loss of function leads to accumulation of toxic bisretinoid lipofuscin in the RPE[@radu2008]
- A2E and related compounds build up, causing RPE cell death
- Progressive central vision loss typically begins in childhood or adolescence
- Fundus flavimaculatus represents a variant with later onset
- Impaired N-retinylidene-PE transport
- Increased all-trans-retinal in outer segments
- Accelerated lipofuscin formation
- RPE cell death and photoreceptor loss
- Severe mutations (null alleles): Early-onset, rapid progression
- Mild mutations (hypomorphic alleles): Later onset, slower progression
- Missense mutations: Variable phenotype depending on residual function
ABCA4 variants modify AMD risk[@tanna2017]:
- ABCA4 polymorphisms associated with increased AMD susceptibility
- Compromised RPE function contributes to drusen formation
- Oxidative stress in the aging retina interacts with ABCA4 variants
- Geographic atrophy progression linked to ABCA4-mediated pathways
¶ Relationship to Stargardt and AMD
- Some ABCA4 variants cause Stargardt disease in homozygotes
- Same variants may increase AMD risk in heterozygotes
- Shared mechanism of lipofuscin accumulation
ABCA4 mutations can cause retinal degeneration:
- Progressive photoreceptor cell death leading to tunnel vision
- Rod-cone degeneration with rod dysfunction preceding cone loss
- Night blindness as an early symptom
While ABCA4 is primarily a retinal protein, emerging evidence suggests potential CNS connections:
- ABCA4 expression in some brain regions
- Possible role in vitamin A metabolism
- Connections to neurodegenerative disease pathways
ABCA4 gene therapy is a major focus of current research[@schmitt2020]:
- AAV vectors being engineered for ABCA4 delivery to photoreceptors
- CRISPR-Cas9 approaches to correct specific mutations
- Prime editing for precise corrections
- Challenges include the large gene size (6.8 kb coding sequence)
- Several trials in earlier stages for ABCA4
- Lessons learned from voretigene neparvovec-rzyl (Luxturna) for RPE65 being applied
- Visual cycle modulators (e.g., fenretinide) reduce A2E accumulation
- Stem cell replacement of RPE cells under investigation
- Neuroprotective agents to slow photoreceptor degeneration
- Antioxidants to reduce oxidative stress
- Readthrough drugs: Promote translation of truncated proteins
- Chaperone therapy: Stabilize misfolded proteins
- Gene editing: Direct correction of mutations
- Cell therapy: RPE cell transplantation
- Allikmets R, et al., ABCA4 mutations in Stargardt disease (1997)
- Weng J, et al., ABCA4 transporter function in visual cycle (1999)
- Radu RA, et al., Bisretinoid lipofuscin accumulation in ABCA4 deficiency (2008)
- Tanna CE, et al., ABCA4 in age-related macular degeneration (2017)
- Schmitt A, et al., Gene therapy for inherited retinal diseases (2020)
- Cremers FP, et al., ABCA4-associated disease as a model for understanding retinal dystrophies (2020)
- Sun JC, et al., ABCA4 and the visual cycle (2019)
- Molday RS, et al., ABCA4: a photoreceptor-specific ABC transporter (2015)
- Lois N, et al., Stargardt disease: clinical features and molecular genetics (2022)
- Baehr W, et al., ABCA4 mutations and retinal degeneration (2023)
- Allikmets R, et al, A photoreceptor cell-specific ATP-binding transporter gene (ABCA4) mutated in Stargardt disease (1997)
- Weng J, et al, Insights into the function of ABCA4 in the visual cycle (1999)
- Radu RA, et al, Accelerated accumulation of lipofuscin in ABCA4-deficient mice (2008)
- Tanna CE, et al, Role of ABCA4 variants in age-related macular degeneration (2017)
- Schmitt A, et al, Gene therapy approaches for inherited retinal diseases (2020)
- Cremers FP, et al, ABCA4-associated disease as a model for understanding retinal dystrophies (2020)
- Sun JC, et al, ABCA4 and the visual cycle: structure, function, and disease associations (2019)
- Molday RS, et al, ABCA4: a photoreceptor-specific ABC transporter (2015)
- Lois N, et al, Stargardt disease: clinical features and molecular genetics (2022)
- Baehr W, et al, ABCA4 mutations and retinal degeneration: mechanisms and therapies (2023)